Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
Messerli
F H
FH
Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121, USA.
Michalewicz
L
L
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D004110:Diltiazem / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000188:drug therapy*; D012008:Recurrence; D014700:Verapamil / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem